Animal models for anxiety and anxiety disorders - Selected models and approaches to study individual differences;Tiermodelle für angst und angststörungen - Ausgewählte modelle und ansätze zur untersuchung individueller differenzen

Psychologische Rundschau

Volumn 57, Issue 3, 2006, Pages 139-153

  Pawlak, Cornelius R ^a,b   Weyers, Peter ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cognition; Conditioned anxiety; Emotion; Fear; GABA; Genetics; Individuality; Serotonin; Unconditioned anxiety; Validity

Indexed keywords

EID: 33746227690     PISSN: 00333042     EISSN: None     Source Type: Journal    
DOI: 10.1026/0033-3042.57.3.139     Document Type: Review

References (116)

1. American Psychiatry Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 1st ed. APA Press, Washington DC.
2. Andreatini, R., Blanchard, C., Blanchard, R., Brandão, M. L., Carobrez, A. P., Griebel, G., Guimarães, F. S., Handley, S. L., Jenck, F., Leite, J. R., Rodgers, J., Schenberg, L. C., Da Cunha, C. & Graeff, F. G. (2001). The brain decade in debate: II: Panic or anxiety? From animal models to a neurobiological basis. Brazilian Journal of Medical and Biological Research, 34, 145-154.
3. Baas, J. M. P., Grillon, C., Böcker, K. B. E., Brack, A. A., Morgan, C. A., Kenemans, L. & Verbaten, M. N. (2002). Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology, 161, 233-247.
4. A receptors. The Journal of Neuroscience, 24, 6343-6351.
5. Ballenger, J. C. (1999). Current treatments of the anxiety disorders in adults. Biological Psychiatry, 46, 1579-1594.
6. Bignami, G. (1965). Selection for high rates and low rates of avoidance conditioning in the rat. Animal Behaviour, 13, 221-227.
7. Bitsios, P., Philpott, A., Langley, R. W., Bradshaw, C. M. & Szabadi, E. (1999). Comparison of the effects of diazepam on the fear-potentiated startle and the fear-inhibited light-reflex in man. Journal of Psychopharmacology, 13, 226-234.
8. Blanchard, D. C. & Blanchard, R. J. (1988). Ethoexperimental approaches to the biology of emotion. Annual Review of Psychology, 39, 43-68.
9. Blanchard, D. C., Griebel, G. & Blanchard, R. J. (2001). Mouse defensive behaviors: Pharmacological and behavioral essays for anxiety and panic. Neuroscience & Biobehavioral Reviews, 25, 205-218.
10. Blizard, D. A. & Adams, N. (2002). The Maudsley Reactive and Nonreactive strains: A new perspective. Behavior Genetics, 32, 277-299.
11. Bolles, R. C. & Fanselow, M. S. (1980). A perceptual-defense- recuperative model of fear and pain. Behavioral and Brain Sciences, 3, 291-323.
12. Borsini, F., Podhorna, J. & Marazziti, D. (2002). Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology, 163, 121-141.
13. Borta, A. & Schwarting, R. K. W. (2005). Post-trial treatment with the nicotinic agonist metanicotine: Differential effects in Wistar rats with high versus low rearing activity. Pharmacology, Biochemistry and Behavior, 80, 541-548.
14. Brown, J. S., Kalish, H. I. & Farber, I. E. (1951). Conditioned fear as revealed by magnitude of startle response to an audi tory stimulus. Journal of Experimental Psychology, 41, 317-328.
15. Canto-de-Souza, A., Nunes-de-Souza, R. L. & Rodgers, R. J. (2002). Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: Influence of prior test experience. Brain Research, 928, 50-59.
16. Carobrez, A. P. & Bertoglio, L. J. (2005). Ethological and temporal analyses of anxiety-like behavior: the elevated plusmaze model 20 years on. Neuroscience and Biobehavioral Reviews, 29, 1193-1205.
17. Connor, K. M. & Davidson, J. R. T. (1998). Generalized anxiety disorder: Neurobiological and pharmacotherapeutic perspectives. Biological Psychiatry, 44, 1286-1294.
18. Connor, T. J., Song, C., Leonard, B. E., Merali, Z. & Anisman, H. (1998). An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience, 84, 923-933.
19. Davis, M. (1998a). Anatomic and physiologic substrates of emotion in an animal model. Journal of Clinical Neurophysiology, 15, 378-387.
20. Davis, M. (1998 b). Are different parts of the extended amygdala involved in fear versus anxiety? Biological Psychiatry, 44, 1239-1247.
21. Davis, M., Falls, W. A., Campeau, S. & Kim, M. (1993). Fear-potentiated startle: A neural and pharmacological analysis. Behavioural Brain Research, 58, 175-198.
22. Davis, M., Redmond Jr., D. E. & Baraban, J. M. 1979. Noradrenergic agonists and antagonists: Effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology, 65, 111-118.
23. Davis, M. & Whalen, P. J. (2001). The amygdala: Vigilance and emotion. Molecular Psychiatry, 6, 13-34.
24. de Jongh, R., Groenink, L., van Der Gugten, J. & Olivier, B. (2002). The light-enhanced startle paradigm as a putative model for anxiety: Effects of chlordiazepoxide, flesinoxan and fluvoxamine. Psychopharmacology, 159, 176-180.
25. Deakin, J. F. W. & Graeff, F. G. (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5, 305-315.
26. Dellu, F., Piazza, P. V., Mayo, W., Le Moal, M. & Simon, H. (1996), Novelty-seeking in rats - biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology, 34, 136-145.
27. Dere, E., De Souza-Silva, M. A., Spieler, R. E., Lin, J. S., Ohtsu, H., Haas, H. L. & Huston, J. P. (2004). Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. European Journal of Neuroscience, 20, 1051-1058.
28. Dubrovksy, B. O. (2005). Steroids, neuroactive steroids and neurosteroids in psychopathology. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 169-192.
29. Dykman, R. A. & Gantt, W. H. (1960). A case of experimental neurosis and recovery in relation to the orienting response. Journal of Psychology, 50, 105-110.
30. Ellenbroek, B. A. & Cools, A. R. (2002). Apomorphine susceptibility and animal models for psychopathology: genes and environment. Behavior Genetics, 32, 349-361.
31. Engel, S. R. & Grant, K. A. (2001). Neurosteroids and behavior. International Review of Neurobiology, 46, 321-348.
32. Fendt, M., Siegl, S. & Steiniger-Brach, B. (2005). Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. The Journal of Neuroscience, 25, 5998-6004.
33. Fernandes, C. & File, S. E. (1996). The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 54, 31-40.
34. Fernández-Teruel, A., Escorihuela, R. M., Gray, J. A., Aguilar, R., Gil, L., Giménez-Llort, L., Tobeña, A., Bhomra, A., Ni cod, A., Mott, R., Driscoll, P., Dawson, G. R. & Flint, J. (2002). A quantitative trait locus influencing anxiety in the laboratory rat. Genome Research, 12, 618-626.
35. File, S. E., Gonzalez, L. E. & Gallant, R. (1998). Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology, 19, 397-405.
36. Finn, D. A., Rutledge-Gorman, M. T. & Crabbe, J. C. (2003). Genetic animal models of anxiety. Neurogenetics, 4, 109-135.
37. Geller, I. & Seifter, J. (1960). The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia, 1, 482-492.
38. Gewirtz, J. C., McNish, K. A. & Davis, M. (1998). Lesions of the bed nucleus of the stria terminalis block sensitization of acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 22, 625-648.
39. Graeff, F. G. (1994). Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in animals. Brazilian Journal of Medical and Biological Research, 27, 811-829.
40. Graeff, F. G. & Zangrossi Jr., H. (2002). Animal models of anxiety. In H. D'haenen, J. A. den Boer & P. Willner (Eds.), Biological Psychiatry (pp. 879-893). Chichester: Wiley.
41. Gray, J. A. (1982). The Neuropsychology of Anxiety. Oxford: Oxford University Press.
42. Gray, J. A. & McNaughton, N. (2000). The Neuropsychology of Anxiety. Oxford: Oxford University Press.
43. Grillon, C. (2002). Startle reactivity and anxiety disorders: Aversive conditioning, context, and neurobiology. Biological Psychiatry, 52, 958-975.
44. Grillon, C., Ameli, R., Woods, S. W., Merikangas, K. & Davis, M. (1991). Fear-potentiated startle in humans: Effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology, 28, 588-595.
45. Grillon, C., Pellowski, M., Merikangas, K. R. & Davis, M. (1997). Darkness facilitates the acoustic startle reflex in humans. Biological Psychiatry, 42, 461-471.
46. 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature, 416, 396-400.
47. Gross, C. & Hen, R. (2004). The developmental origins of anxiety. Nature Reviews Neuroscience, 5, 545-552.
48. Hall, C. S. (1934). Emotional behavior in the rat. I Defecation and urination as measures of individual differences in emotionality. Journal of Comparative Psychology, 18, 385-403.
49. Hamilton, J. A. & Ballachey, E. L. (1934) An instance of Umweg behavior in the rat. Journal of Genetic Psychology, 45,260-261
50. Hamm, A. O. & Vaitl, D. (1996). Affective learning: Awareness and aversion. Psychophysiology, 33, 451-458.
51. Handley, S. L. & McBlane, J. W. (1993). 5-HT drugs in animal models of anxiety. Psychopharmacology, 112, 13-20.
52. Ho, Y. J., Eichendorff, J. & Schwarting R. K. W. (2002). Individual profiles of male Wistar rats in animal models of anxiety and depression. Behavioural Brain Research, 136, 1-12.
53. Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M. & Otto, M. W. (2006). Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298-304.
54. 1A receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology, 28, 2077-2088.
55. Holsboer, F. (1999). The rationale for corticotropin-releasing hormone receptor (CRH-H) antagonists to treat depression and anxiety. Journal of Psychiatric Research, 33, 181-214.
56. Huber, D., Veinante, P. & Stoop, R. (2005). Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science, 308, 245-248.
57. Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F. & Landgraf, R. (2003). Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology, 28, 235-243.
58. Kehne, J. H. & Davis, M. (1985). Central norardenergic involvement in yohimbine excitation of acoustic startle: Effects of DSP4 and 6-OHDA. Brain Research, 330, 31-41.
59. Koch, M. (1999). The neurobiology of startle. Progress in Neurobiology, 59, 107-128.
60. Koch, M. & Fendt, M. (2003). Startle response modulation as a behavioral tool in neuropsychopharmacology. Current Neuropharmacology, 1, 175-185.
61. Landgraf, R. & Wigger, A. (2002). High vs low anxiety-related behavior rats: An animal model of extremes in trait anxiety. Behavior Genetics, 32, 301-314.
62. Lang, P. J., Bradley, M. M. & Cuthbert, B. N. (1990). Emotion, attention, and the startle reflex. Psychological Review, 97, 377-395.
63. Lathe, R. (2004). The individuality of mice. Genes, Brain and Behavior, 3, 317-327.
64. LeDoux, J. E. (1987). Emotion. In F. Plum (Ed.), Handbook of Physiology: Sec. 1, Neurophysiology: Vol 5. Higher Functions of the Brain (pp. 416-459). Bethesda, MD: American Physiological Society.
65. LeDoux, J. E. (1995). Emotion: Clues from the brain. Annual Review of Psychology, 46, 209-235.
66. Liebsch, G., Wotjak, C. T., Landgraf, R. & Engelmann, M. (1996). Septal vasopressin modulates anxiety-related behaviour in rats. Neuroscience Letters, 217, 101-104.
67. Marks, I. M. (1987). Fears, Phobias, and Rituals: Panic, Anxiety, and Their Disorders. New York: Oxford University Press.
68. Mineka, S. & Tomarken, A. J. (1989). The role of cognitive biases in the origins and maintenance of fear and anxiety disorders. In T. Archer & L.-G. Nilsson (Eds.), Aversion, Avoidance and Anxiety: Perspectives on Aversively Motivated Behavior (pp. 195-221). Hilsdale, New Jersey: Erlbaum.
69. Montgomery, K. C. (1958). The relation between fear induced by novel stimulation and exploratory behaviour. Journal of Comparative and Physiological Psychology, 48, 254-260.
70. Morgan, C. A., Southwick, S. M., Grillon, C., Davis, M., Krystal, J. H. & Charney, D. S. (1993). Yohimbine - facilitated acoustic startle reflex in humans. Psychopharmacology, 110, 342-346.
71. Morgan, C. A., Grillon, C., Southwick, S. M., Nagy, S. M., Davis, M., Krystal, J. H. & Charney, D. S. (1995). Yohimbine facilitated acoustic startle in combat veterans with posttraumatic stress disorder. Psychopharmacology, 117, 466-471.
72. Mucha, R. F. (1998). Grundlagen der angewandten Motivationsforschung. In E. Irle & H. J. Markowitsch (Hrsg.), Enzykopädie der Psychologie: Vergleichende Psychobiologie (S. 541-652). Göttingen: Hogrefe.
73. Müller, M. B., Zimmermann, S., Sillaber, I., Hagemeyer, T. P., Deussing, J. M., Timpl, P., Kormann, M. S. D., Droste, S. K., Kühn, R., Reul, J. M. H. M., Holsboer, F. & Wurst, W. (2003). Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience, 6, 1100-1107.
74. Murgatroyd, C., Wigger, A., Frank, E., Singewald, N., Bunck, M., Holsboer, F., Landgraf, R. & Spengler, D. (2004). Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. The Journal of Neuroscience, 24, 7762-7770.
75. Nunes-de-Souza, R. L., Canto-de-Souza, A. & Rodgers, R. J. (2002). Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Research, 927, 87-96.
76. Panksepp, J. (1982). Toward a general psychobiological theory of emotions. Behavioural and Brain Sciences, 5, 407-467.
77. Paul, E. S., Harding, E. J. & Mendl, M. (2005). Measuring emotional processes in animals: The utility of a cognitive approach. Neuroscience & Biobehavioral Reviews, 29, 469491.
78. Pauli, P., Diedrich, O. & Müller, A. (2002). Covariation bias in the affect-modulated startle paradigm. Journal of Behavior Therapy & Experimental Psychiatry, 33, 191-202.
79. Pauli P., Montoya, P. & Martz, G.-E. (1996). Covariation bias in panic-prone individuals. Journal of Abnormal Psychology, 105, 658-662.
80. Pawlak, C. R., Ho, Y. J., Schwarting, R. K. W. & Bauhofer, A. (2003). Relationship between striatal levels of interleukin-2 mRNA and plus-maze behaviour in the rat. Neuroscience Letters, 341, 205-208.
81. Pawlak, C. R. & Schwarting, R. K. W. (2002). Object preference and nicotine consumption in rats with high vs. low rearing activity in a novel open field. Pharmacology, Biochemistry and Behavior, 73, 679-687.
82. Pawlak, C. R. & Schwarting, R. K. W. (2006). Striatal microin-jections of interleukin-2 and rat behaviour in the elevated plus-maze. Behavioural Brain Research, 168, 339-344.
83. Pawlak, C. R. & Schwarting, R. K. W. (2006). Striatal microin-jections of interleukin-2 affects rat behaviour in an open field. Manuscript in preparation.
84. Pawlak, C. R., Schwarting, R. K. W. & Bauhofer, A. (2005). Cytokine mRNA levels in brain and peripheral tissues of the rat: Relationships with plus-maze behaviour. Brain Research Molecular Brain Research, 137, 159-165.
85. Pellow, S., Chopin, P., File, S. E. & Briley, M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
86. Pinel, J. P. J. & Treit, D. (1978). Burying as a defensive response in rats. Journal of Comparative and Physiological Psychology, 92, 708-712.
87. Pinel, J. P. J. & Wilkie, D. M. (1983). Conditioned defensive burying: A biological and cognitive approach to avoidance learning. In R. L. Mellgren (Ed.), Animal Cognition and Behaviour (pp. 285-318). Amsterdam: North-Holland Publishing.
88. Ramos, A. & Morméde, P. (1998). Stress and emotionality: A multidimensional and genetic approach. Neuroscience & Biobehavioral Reviews, 22, 33-57.
89. Rapoport, J. L. (1991). Recent advances in obsessive-compulsive disorder. Neuropsychopharmacology, 5, 1-10.
90. Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L. & Davis, M. (2004). Cognitive enhancers as adjuncts to psychotherapy. Use of d-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry, 61, 1136-1144.
91. Riba, J., Rodriguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R. & Barbanoj, M. J. (2001). Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: A dose-response study. Psychopharmacology, 157, 358-367.
92. Rodgers, R. J. (1997). Animal models of 'anxiety': Where next? Behavioural Pharmacology, 8, 477-496.
93. Rodgers, R. J., Cao, B. J., Dalvi, A. & Holmes, A. (1997). Animal models of anxiety: An ethological perspective. Brazilian Journal of Medical and Biological Research, 30, 289-304.
94. Sarter, M. & Markowitsch, H. J. (1985). Involvement of the amygdala in learning and memory: A critical review, with emphasis on anatomical relations. Behavioral Neuroscience, 99, 342-380.
95. Schwabe, K., Klein, S. & Koch, M. (2006). Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. Behavioural Brain Research, 168, 150-160.
96. Schwarting, R. K. W., Thiel, C. M., Müller, C. P. & Huston, J. P. (1998). Relationship between anxiety and serotonin in the ventral striatum. NeuroReport, 9, 1025-1029.
97. Schwarting, R. K. W. & Pawlak, C. R. (2004). Behavioral neuroscience in the rat: Taking the individual into account. Methods and Findings in Experimental and Clinical Pharmacology, 26, Suppl. 2, 17-22.
98. Schweimer, J., Fendt, M. & Schnitzler, H. U. (2005). Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats. European Journal of Pharmacology, 507, 117-124.
99. Seligman, M. E. P. (1970). On the generality of the laws of learning. Psychological Review, 77, 406-418.
100. Steimer, T. & Driscoll, P. (2005). Inter-individual vs line/strain differences in psychogenetically selected Roman High-(RHA) and Low-(RLA). Avoidance rats: neuroendocrine and behavioural aspects. Neuroscience & Biobehavioral Reviews, 29, 99-112.
101. Stein, D. J. & Bouwer, C. (1997). A neuro-evolutionary approach to the anxiety disorders. Journal of Anxiety Disorders, 4, 409-429.
102. Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A. & Schoepp, D. D. (2005). Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nature Reviews Drug Discovery, 4, 131-146.
103. Swerdlow, N. R., Geyer, M. A., Vale, W. W. & Koob, G. F. (1996). Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. Psychopharmacology, 88, 147-152.
104. Thiel, C. M., Müller, C., Huston, J. P. & Schwarting, R. K. W. (1999). High vs. low reactivity to a novel environment: Behavioural, pharmacological and neurochemical assessments. Neuroscience, 93, 243-251.
105. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F. & Wurst, W. (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics, 19, 162-166.
106. Toufexis, D. J., Davis, C., Hammond, A. & Davis, M. (2004). Progesterone attenuates corticotropin-releasing factor-enhanced baut not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. The Journal of Neuroscience, 24, 10280-10287.
107. Treit, D. (1985). Animal models for the study of anti-anxiety agents: A review. Neuroscience & Biobehavioral Reviews, 9, 203-222.
108. van Gaalen, M. M., Stenzel-Poore, M. P., Holsboer, F. & Steckler, T. (2002). Effects of transgenic overproduction of CRH on anxiety-like behaviour. European Journal of Neuroscience, 15, 2007-2015.
109. Walker, D. L. & Davis, M. (1997). Anxiogenic effects of high illumination levels assessed with the acoustic startle paradigm. Biological Psychiatry, 42, 461-471.
110. Walker, D., Ressler, K. J., Lu, K.-T. & Davis, M. (2002) Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. The Journal of Neuroscience, 22, 2343-2351.
111. Walker, D. L., Toufexis, D. J. & Davis, M. (2003). Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. European Journal of Pharmacology, 463, 199-216.
112. Wall, P. M. & Messier, C. (2001). Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neuroscience & Biobehavioral Reviews, 25, 275-286.
113. Wichers, M. & Maes, M. (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology, 5, 375-388.
114. Wigger, A., Sánchez, M. M., Mathys, K. C., Ebner, K., Frank, E., Liu, D., Kresse, A., Neumann, I. D., Holsboer, F., Plotsky, P. M. & Landgraf, R. (2004). Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: Critical role of vasopressin. Neuropsychopharmacology, 29, 1-14.
115. Willner, P. (1984). The validity of animal models of depression. Psychopharmacology, 83, 1-16.
116. Yilmazer-Hanke, D. M., Faber-Zuschratter, H., Linke, R. & Schwegler, H. (2002). Contribution of amygdala neurons containing peptides and calcium-binding proteins to fear-potentiated startle and exploration-related anxiety in inbred Roman high- and low-avoidance rats. European Journal of Neuroscience, 15, 1206-1218.